COVID-19
Brazilian volunteer in COVID-19 vaccine trial dies
Brazilian health authority Anvisa confirmed a volunteer in a clinical trial of the COVID-19 vaccine developed by AstraZeneca and Oxford University had died but said the trial would continue.
Oxford confirmed the plan to keep testing, saying in a statement that after careful assessment “there have been no concerns about safety of the clinical trial,” Reuters reported.
A source told Reuters the trial would have been suspended if the volunteer who died had received the COVID-19 vaccine, suggesting the person was part of the control group that was given a meningitis vaccination.
The Federal University of Sao Paulo, which confirmed the volunteer was Brazilian, said a review committee had suggested the trial continue.
The university is helping to coordinate phase 3 clinical trials in Brazil.
